Global Pharmaceuticals & Biotech Most Popular Stocks

Pharming Group

Market Cap: €770.8m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Sana Biotechnology

Market Cap: US$888.4m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Tango Therapeutics

Market Cap: US$886.7m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Immunome

Market Cap: US$883.9m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Shanghai Kaibao PharmaceuticalLtd

Market Cap: CN¥6.3b

Engages in the research, development, production, and sale of modern Chinese medicines primarily in China.

Hangzhou Bio-Sincerity Pharma-TechLtd

Market Cap: CN¥6.3b

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Oxford Biomedica

Market Cap: UK£657.4m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Upstream Bio

Market Cap: US$879.3m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

GNI Group

Market Cap: JP¥131.3b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

HK inno.N

Market Cap: ₩1.2t

Engages in the pharmaceutical business in South Korea.

L&C BIOLTD

Market Cap: ₩1.2t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Novogene

Market Cap: CN¥6.2b

Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.

CorMedix

Market Cap: US$868.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

MedinCell

Market Cap: €741.3m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Jianmin Pharmaceutical GroupLtd

Market Cap: CN¥6.2b

Manufactures and sells medicines in China.

Qyuns Therapeutics

Market Cap: HK$6.7b

A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

Immatics

Market Cap: US$857.0m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

Ocumension Therapeutics

Market Cap: HK$6.6b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Shilpa Medicare

Market Cap: ₹75.3b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

ChengDu ShengNuo BiotecLtd

Market Cap: CN¥6.1b

Engages in the research and development, production, sale, and export of peptide drugs.

Valneva

Market Cap: €725.4m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Strides Pharma Science

Market Cap: ₹75.2b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Jiangsu Aidea Pharmaceutical Group

Market Cap: CN¥6.0b

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Shenzhen Weiguang Biological Products

Market Cap: CN¥6.0b

Shenzhen Weiguang Biological Products Co., Ltd.

Aarti Pharmalabs

Market Cap: ₹74.7b

Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

Marksans Pharma

Market Cap: ₹74.5b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Taysha Gene Therapies

Market Cap: US$834.8m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

FDC

Market Cap: ₹74.0b

Manufactures and trades in pharmaceutical products in India, the United States, and internationally.

Jinghua Pharmaceutical Group

Market Cap: CN¥5.9b

Engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China.

GH Research

Market Cap: US$831.2m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Mega Lifesciences

Market Cap: ฿26.8b

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.

Jiangsu Yahong Meditech

Market Cap: CN¥5.9b

A pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally.

Arbutus Biopharma

Market Cap: US$828.1m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Kodiak Sciences

Market Cap: US$826.4m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Sopharma AD

Market Cap: лв1.4b

Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

Inventiva

Market Cap: €702.5m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.